title: In vivo use of OKT3: main issues for the monitoring of treated patients.
authors: INSERM U 25, Hôpital Necker, Paris, France.
authors: L
authors: L
authors: Chatenoud
authors: C
authors: C
authors: Ferran
authors: J F
authors: JF
authors: Bach
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000032:analysis; D006801:Humans; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D008212:Lymphocyte Depletion; D015166:Monitoring, Immunologic; D016853:Muromonab-CD3; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D016853:Muromonab-CD3